ImmunityBio presented interim results from its phase 2 metastatic pancreatic cancer trial (QUILT 88) evaluating its NANT Cancer vaccine, comprising ImmunityBio’s IL-15 receptor agonist Anktiva…
HOOKIPA Pharmaceuticals announced that the first patient has been dosed with HB-200 in combination with pembrolizumab (Keytruda, Merck) for the treatment of 1st-line advanced/metastatic Human…
Jacobio Pharma announced the U.S FDA has approved an IND (Investigational New Drug) for its first-in-class drug Aurora A inhibitor JAB-2485. The company is moving…
Founded by Chinese biotech entrepreneur Wei William Cao, Suzhou, China headquartered Gracell Biotechnologies Co., Ltd (Gracell) is on a mission to bring best-in-class and economical cellular…
Penn State researchers focusing on muscle loss led by Gustavo Nader, associate professor of kinesiology and physiology, and principal investigator, received $2 million from the…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
